Cyclodextrin host-guest complex to facilitate sinomenine-based osteoporosis therapy.

Area of Science:

• Pharmacology
• Drug Delivery
• Materials Science

Background:

• Sinomenine (SIN), a traditional Chinese medicine, shows potential for osteoporosis treatment via autophagy modulation.
• Current administration methods using dimethyl sulfoxide limit clinical injectable development.
• Effective solubilization is crucial for developing injectable SIN formulations.

Purpose of the Study:

• To compare various solubilization techniques for sinomenine (SIN).
• To evaluate the efficacy of host-guest inclusion for SIN solubilization.
• To assess the potential of SIN-β-cyclodextrin complexes for osteoporosis treatment.

Main Methods:

• Comparison of solubilization techniques: amorphisation, emulsification, micellisation, nano-crystallisation, and host-guest inclusion.
• Selection of β-cyclodextrin as the host agent for host-guest inclusion.
• Evaluation of solubility, stability, release rate, and bioavailability of SIN formulations.

Main Results:

• Host-guest inclusion significantly enhanced SIN solubility and stability.
• This method increased SIN release rate and improved bioavailability.
• β-cyclodextrin demonstrated excellent biocompatibility and encapsulation efficiency.

Conclusions:

• Host-guest inclusion is a promising strategy for solubilizing sinomenine (SIN).
• SIN-β-cyclodextrin complexes show potential for clinical application in osteoporosis treatment.
• Further evaluation of safety, efficacy, and regulatory compliance is necessary for clinical translation.